BLC
NVO

Brown, Lisle/Cummings’s Novo Nordisk NVO Stock Holding History

Brown, Lisle/Cummings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Buy
59,224
+20
+0% +$859 0.64% 39
2026
Q1 		$2.18M Buy
59,204
+109
+0.2% +$5.17K 0.54% 44
2025
Q4 		$3.01M Buy
59,095
+4,212
+8% +$215K 0.74% 35
2025
Q3 		$3.05M Sell
54,883
-1,171
-2% -$68.5K 0.78% 32
2025
Q2 		$3.87M Buy
56,054
+125
+0.2% +$8.5K 1.03% 23
2025
Q1 		$3.88M Buy
55,929
+7,071
+14% +$584K 1.13% 20
2024
Q4 		$4.2M Sell
48,858
-1,337
-3% -$145K 1.25% 18
2024
Q3 		$5.98M Buy
50,195
+7,200
+17% +$960K 1.82% 10
2024
Q2 		$6.14M Sell
42,995
-1,070
-2% -$142K 2% 9
2024
Q1 		$5.66M Sell
44,065
-225
-0.5% -$26.8K 1.92% 9
2023
Q4 		$4.58M Buy
44,290
+7,000
+19% +$692K 1.7% 10
2023
Q3 		$3.39M Buy
37,290
+3,700
+11% +$326K 1.53% 15
2023
Q2 		$2.72M Sell
33,590
-430
-1% -$35.1K 1.22% 21
2023
Q1 		$2.71M Sell
34,020
-7,430
-18% -$527K 1.37% 17
2022
Q4 		$2.8M Hold
41,450
– – 1.51% 16
2022
Q3 		$2.06M Sell
41,450
-250
-0.6% -$13.4K 1.21% 20
2022
Q2 		$2.32M Sell
41,700
-450
-1% -$25K 1.29% 19
2022
Q1 		$2.34M Buy
42,150
+4,800
+13% +$246K 1.12% 21
2021
Q4 		$2.09M Buy
+37,350
New +$2.02M 1.05% 21

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Brown, Lisle/Cummings's NVO Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Novo Nordisk (NVO) stake by 0.03% in Q2 2026, buying an estimated $859 and bringing the position to 59,224 shares worth $2.84M. The position accounts for 0.64% of the portfolio, ranked #39.

Brown, Lisle/Cummings first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.14M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Brown, Lisle/Cummings held 59,224 shares of Novo Nordisk worth $2.84M as of Q2 2026.
  • Brown, Lisle/Cummings bought 20 Novo Nordisk shares in Q2 2026, an estimated $859.
  • Novo Nordisk made up 0.64% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #39 holding.
  • Brown, Lisle/Cummings first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Novo Nordisk position peaked at $6.14M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.